Founded in 2006, Nanovis’s mission is to lead our
markets with science driven, life-improving technology.

Our values are integrity, profitability, discovery, and being the solution.

Birck Nanotechnology Center 3Nanovis portfolio of implant nanosurfaces, nanostructured biomaterials and bone growth peptides allows us to design and manufacture implant nanosurfaces, implantable scaffolds or injectable biomaterials, with tissue growth properties that are superior to conventional materials or therapeutics. Nanovis is advancing important nanostructured biomaterial and nanosurfaced implant programs alone and in conjunction with strategic partners. Due to confidentiality and intellectual property factors only a portion of Nanovis’ technology is described here.